Greenwich LifeSciences(GLSI)
$15.28-0.81 (-5.03%)
GLSI
Greenwich LifeSciences financials statements
$15.28
At close:-0.81 (-5.03%)
Greenwich LifeSciences (GLSI) Income Statement
451 Followers
Greenwich LifeSciences Income Statement
Last quarter (Q2 2026), Greenwich LifeSciences's total revenue was $0.00. In Q2, Greenwich LifeSciences's net income was $-3.95M. See Greenwich LifeSciences’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ -1.78K | $ -3.61K | $ -3.61K | $ -3.61K | $ -3.61K | |
| $ 19.45M | $ 17.63M | $ 9.32M | $ 8.04M | $ 4.59M | |
| Depreciation and Amortization | $ 1.78K | $ 3.61K | $ 3.61K | $ 3.61K | $ 3.61K |
| $ -19.36M | $ -17.41M | $ -8.89M | $ -7.82M | $ -4.57M | |
| $ -19.45M | $ -17.64M | $ -9.33M | $ -8.04M | $ -4.60M | |
| $ 89.70K | $ 223.01K | $ 436.06K | $ 215.02K | $ 27.37K | |
| $ -19.36M | $ -17.41M | $ -8.89M | $ -7.83M | $ -4.57M | |
| $ -19.36M | $ -17.41M | $ -8.89M | $ -7.83M | $ -4.57M | |
| Per Share Metrics | |||||
| Basic EPS | $ -1.43 | $ -1.21 | $ -0.69 | $ -0.61 | $ -0.35 |
| Diluted EPS | $ -1.43 | $ -1.21 | $ -0.69 | $ -0.61 | $ -0.35 |
| Weighted Average Shares Outstanding | 13.53M | 13.01M | 12.85M | 12.91M | 12.94M |
| Weighted Average Shares Outstanding (Diluted) | 13.53M | 13.01M | 12.85M | 12.91M | 12.94M |
Currency in USD
